Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: To standardize recruitment, participants must meet all of the following criteria: The pathological result of prostate biopsy is diagnosed as malignant prostate tumor. According to the D'Amico risk classification, they are considered high-risk, meeting one of the following conditions: a. PSA > 20ng/mol, b. GS > 7 (ISUP grades 4-5), c. Clinical staging of = cT2c. Life expectancy > 5 years. (According to WHO's life table by country, for Chinese males, i.e. under the age of 85) They agree to participate in the trial and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will be excluded from the study: History of prostate surgery, pelvic surgery, or urethral surgery. History of neoadjuvant radiotherapy. Concurrent neurogenic urinary dysfunction or urethral stricture. Clinical T4 or M1 staging.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative social urinary continence rate at 3 months; | — |
Secondary
| Measure | Time frame |
|---|---|
| Instant urinary continence condition;ICIQ-UI-SF score at 3 months postoperatively;Postoperative urinary continence condition at 1 month and 6 months; | — |
Countries
China
Contacts
The First Affiliated Hospital of China Medical University